Has Kyle Dearing, OD received payments from drug or device companies?

Yes. Drug and device makers reported $1,771 in general payments to Kyle Dearing, OD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Dearing, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Dearing, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Dearing, OD

Optometrist · Klamath Falls, ORNPI 1346809787

Payments from drug & device makers

$1,771in general payments, 2019–2025

Across 14 payments — averaging $126.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Carl Zeiss Meditec USA, Inc.$1K
Alcon$224
Regeneron Healthcare Solutions, Inc.$121
Sight Sciences, Inc.$43
Biotissue Holdings Inc.$17
AbbVie$15
plus $30 from 2 others

What the payments were for

Travel & lodging$1,08061%
Food & beverage$69139%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Carl Zeiss Meditec USA, Inc.	3	$1,323
Alcon	5	$224
Regeneron Healthcare Solutions, Inc.	1	$121
Sight Sciences, Inc.	1	$43
Biotissue Holdings Inc.	1	$17
AbbVie	1	$15
Omeros Corporation	1	$15
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,771 in reported general payments places this provider in the 80th percentile of 684 optometrist providers in Oregon.

See all optometrist providers in Oregon →

Medicare billing

Part B allowed, 2024

$141,273

Medicare patients

640

Services billed

1,428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Latanoprost	132	$1,274
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat	35	$543
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	27	$354
Timolol Maleate	25	$236

Paid to pharmacies, not to this prescriber.

Other optometrist in Klamath Falls

Amber DunnKing City$284K
Roger TabbPortland$239K
Mila IoussifovaPortland$223K
Cristina SchniderForest Grove$204K
Tracy DollPortland$164K
Yue LiuForest Grove$149K
Shajida Espat ReichMedford$87K
Bradley SmithTigard$85K
Christi ClossonForest Grove$80K
Frank ZhengForest Grove$78K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →